Bloom Science, Inc. is a biotechnology company focused on discovering, developing and commercializing live biotherapeutics to treat unmet neurological and inflammatory diseases. Bloom’s team of scientists, data-geeks and never-say-die entrepreneurs are rethinking how medicines are developed that can take advantage of our expanding insight into the role our gut microbiome plays in modulating key processes in the brain and immune system.
Bloom has developed IrisRx, a best-in-class microbiome focused drug discovery platform, using a reverse translational approach of demonstrated clinical treatments into de-risked therapeutic opportunities utilizing rational selection and engineering of keystone human gut microbiota.
For more information, please visit www.bloomscience.com
Bloom has developed IrisRx, a best-in-class microbiome focused drug discovery platform, using a reverse translational approach of demonstrated clinical treatments into de-risked therapeutic opportunities utilizing rational selection and engineering of keystone human gut microbiota.
For more information, please visit www.bloomscience.com
Location: United States, California, San Diego
Employees: 11-50
Total raised: $12M
Founded date: 2018
Investors 3
| Date | Name | Website |
| - | Joyance Pa... | joyancepar... |
| 10.03.2024 | PsyMed Ven... | psymed.ven... |
| 10.01.2021 | Social Sta... | socialstar... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.12.2021 | Series A | $12M | - |
Mentions in press and media 7
| Date | Title | Description |
| 02.10.2022 | The Foundation of our Food and Drink Focus | The first time we officially declared Food as a focus area was in the spring of 2018. “We see an impending tech-driven revolution in food, top to bottom,” we proclaimed. The never-ending hunt for new ingredients can indicate what people are... |
| 02.10.2022 | The Motivation Behind our Microbiome Focus | Photo by CDC on Unsplash Scientific exploration of the microbiome represents the opening of one of the greatest areas of science in decades, perhaps centuries. The biome utterly defines novel new approaches to the prevention and treatment ... |
| 23.12.2021 | Bloom Science Raises $12M in Series A | San Diego-based biotech company Bloom Science has closed a $12 million Series A financing round with a syndicate of life science investors led by Leaps by Bayer, the impact investment arm of Bayer AG, and the ALS Investment Fund. Additional... |
| 10.12.2021 | Bloom Science Garners $12M in Series A Funding to advance its pipeline | - |
| 09.12.2021 | Bloom Science Scores $12M | San Diego=based Bloom Science, a biotech startup developing microbiome-based treatments for neurological and inflammatory disease, says it has raised $12M in its Series A funding. The funding was led by Leaps by Bayer, the impact investment... |
| 09.12.2021 | Bloom Science Raises $12M in Series A Financing | Bloom Science, a San Diego, CA-based biotech company, closed a USD $12m Series A financing. The round was led by Leaps by Bayer, the impact investment arm of Bayer AG, and the ALS Investment Fund. Additional investors include Apollo Health ... |
| 01.10.2020 | Trusting Your Gut: How Our Portfolio Companies are Taking Advantage of the Microbial Revolution | Last month marked an important step for microbiome science: Cambridge, MA-based biotechnology company Seres Therapeutics reported positive results from their Phase III human clinical trial of an oral microbiome therapeutic for the treatment... |